Literature DB >> 34244154

Economic Evaluation of Web- versus Telephone-based Interventions to Simultaneously Increase Colorectal and Breast Cancer Screening Among Women.

Danmeng Huang1, David R Lairson2, Tong H Chung1, Patrick O Monahan3, Susan M Rawl4,5, Victoria L Champion4,5.   

Abstract

Screening for colorectal and breast cancer is considered cost effective, but limited evidence exists on cost-effectiveness of screening promotion interventions that simultaneously target both cancers. Increasing Colorectal and Breast Cancer Screening (Project COBRA), a randomized controlled trial conducted in the community, examined the cost-effectiveness of an innovative tailored web-based intervention compared with tailored telephone counseling and usual care. Screening status at 6 months was obtained by participant surveys plus medical record reviews. Cost was prospectively measured from the patient and provider perspectives using time logs and project invoices. Relative efficiency of the interventions was quantified by the incremental cost-effectiveness ratios. Nonparametric bootstrapping and net benefit regression analysis were used to assess statistical uncertainty of the results. The average cost per participant to implement the Phone counseling, Web-based, and Web + Phone counseling interventions were $277, $314, and $337, respectively. Comparing Phone counseling with usual care resulted in an additional cost of $300 (95% confidence interval [CI]: $283-$320) per cancer screening test and $421 (95% CI: $400-$441) per additional person screened in the target population. Phone counseling alone was more cost-effective than the Web + Phone intervention. Web-based intervention alone was more costly but less effective than the Phone counseling. When simultaneously promoting screening for both colorectal and breast cancer the Web-based intervention was less cost-effective compared with Phone and Web + Phone strategies. The results suggest that targeting multiple cancer screening may improve the cost-effectiveness of cancer screening interventions. PREVENTION RELEVANCE: This study informs researchers, decision makers, healthcare providers, and payers about the improved cost-effectiveness of targeting multiple cancer screenings for cancer early detection programs. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34244154      PMCID: PMC8416925          DOI: 10.1158/1940-6207.CAPR-21-0009

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  31 in total

1.  A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same.

Authors:  Sally W Vernon; Leona K Bartholomew; Amy McQueen; Judy L Bettencourt; Anthony Greisinger; Sharon P Coan; David Lairson; Wenyaw Chan; S T Hawley; R E Myers
Journal:  Ann Behav Med       Date:  2011-06

2.  Effects of a tailored interactive multimedia computer program on determinants of colorectal cancer screening: a randomized controlled pilot study in physician offices.

Authors:  Anthony Jerant; Richard L Kravitz; Mairin Rooney; Scott Amerson; Matthew Kreuter; Peter Franks
Journal:  Patient Educ Couns       Date:  2006-12-06

3.  Recommendations for client- and provider-directed interventions to increase breast, cervical, and colorectal cancer screening.

Authors: 
Journal:  Am J Prev Med       Date:  2008-07       Impact factor: 5.043

4.  NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018.

Authors:  Dawn Provenzale; Samir Gupta; Dennis J Ahnen; Arnold J Markowitz; Daniel C Chung; Robert J Mayer; Scott E Regenbogen; Amie M Blanco; Travis Bray; Gregory Cooper; Dayna S Early; James M Ford; Francis M Giardiello; William Grady; Michael J Hall; Amy L Halverson; Stanley R Hamilton; Heather Hampel; Jason B Klapman; David W Larson; Audrey J Lazenby; Xavier Llor; Patrick M Lynch; June Mikkelson; Reid M Ness; Thomas P Slavin; Shajanpeter Sugandha; Jennifer M Weiss; Mary A Dwyer; Ndiya Ogba
Journal:  J Natl Compr Canc Netw       Date:  2018-08       Impact factor: 11.908

Review 5.  Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening.

Authors:  Robert A Smith; Kimberly S Andrews; Durado Brooks; Stacey A Fedewa; Deana Manassaram-Baptiste; Debbie Saslow; Richard C Wender
Journal:  CA Cancer J Clin       Date:  2019-03-15       Impact factor: 508.702

6.  A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening.

Authors:  Ronald E Myers; Randa Sifri; Terry Hyslop; Michael Rosenthal; Sally W Vernon; James Cocroft; Thomas Wolf; Jocelyn Andrel; Richard Wender
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

7.  Tailored interventions to promote mammography screening: a meta-analytic review.

Authors:  Stephanie J Sohl; Anne Moyer
Journal:  Prev Med       Date:  2007-06-23       Impact factor: 4.018

8.  A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening.

Authors:  Ronald E Myers; Heather Bittner-Fagan; Constantine Daskalakis; Randa Sifri; Sally W Vernon; James Cocroft; Melissa Dicarlo; Nora Katurakes; Jocelyn Andrel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-01       Impact factor: 4.254

9.  A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings.

Authors:  Sharon L Manne; Elliot J Coups; Arnold Markowitz; Neal J Meropol; Daniel Haller; Paul B Jacobsen; Lina Jandorf; Susan K Peterson; Samuel Lesko; Steven Pilipshen; Gary Winkel
Journal:  Ann Behav Med       Date:  2009-04

Review 10.  What implementation interventions increase cancer screening rates? a systematic review.

Authors:  Melissa C Brouwers; Carol De Vito; Lavannya Bahirathan; Angela Carol; June C Carroll; Michelle Cotterchio; Maureen Dobbins; Barbara Lent; Cheryl Levitt; Nancy Lewis; S Elizabeth McGregor; Lawrence Paszat; Carol Rand; Nadine Wathen
Journal:  Implement Sci       Date:  2011-09-29       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.